-
1
-
-
0027229177
-
Expression of antitumor response: Role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells
-
AKAZA, H., IWASAKI, A., OHTANI, M., IKEDA, N., NIIJIMA, K., TOIDA, I. and KOISO, K., Expression of antitumor response: role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells. Cancer, 72, 558-563 (1993).
-
(1993)
Cancer
, vol.72
, pp. 558-563
-
-
Akaza, H.1
Iwasaki, A.2
Ohtani, M.3
Ikeda, N.4
Niijima, K.5
Toida, I.6
Koiso, K.7
-
2
-
-
0026718870
-
Recurrent or aggressive bladder cancer: Indications for adjutant intravesical therapy
-
BADALAMENT, R.A., ORTOLANO, V. and BURGERS, J.K., Recurrent or aggressive bladder cancer: indications for adjutant intravesical therapy. Urol. Clin. North Amer., 19, 485-498 (1992).
-
(1992)
Urol. Clin. North Amer.
, vol.19
, pp. 485-498
-
-
Badalament, R.A.1
Ortolano, V.2
Burgers, J.K.3
-
3
-
-
0025823180
-
Internalization of bacillus Calmette-Guérin by bladder tumour cells
-
BECICH, M.J., CARROLL, S. and RATLIFF, T.L., Internalization of bacillus Calmette-Guérin by bladder tumour cells. J. Urol., 145, 1316-1324 (1991).
-
(1991)
J. Urol.
, vol.145
, pp. 1316-1324
-
-
Becich, M.J.1
Carroll, S.2
Ratliff, T.L.3
-
4
-
-
0025351905
-
Effect of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall
-
BOHLE, A., GERDES, J., ULMER, A.J., HOFSTETTER, A.G. and FLAD, H.D., Effect of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol., 144, 53-58 (1990).
-
(1990)
J. Urol.
, vol.144
, pp. 53-58
-
-
Bohle, A.1
Gerdes, J.2
Ulmer, A.J.3
Hofstetter, A.G.4
Flad, H.D.5
-
5
-
-
0027742001
-
Dissecting the immunobiological effects of bacillus CalmetteGuérin (BCG) in vitro: Evidence of a distinct BCG-activated killer (BAK) cell phenomenon
-
BOHLE, A., THANHAUSER, A., ULMER, A.J., ERNST, M., FLAD, H.D. and JOCHAM, D., Dissecting the immunobiological effects of bacillus CalmetteGuérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon. J. Urol., 150, 1932-1937 (1993).
-
(1993)
J. Urol.
, vol.150
, pp. 1932-1937
-
-
Bohle, A.1
Thanhauser, A.2
Ulmer, A.J.3
Ernst, M.4
Flad, H.D.5
Jocham, D.6
-
6
-
-
0021125689
-
Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro
-
BORDEN, E.C., GROVEMAN, D.S., NASU, T., REZNIKOFF, C. and BRYAN, G.T., Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J. Urol., 132, 800-803 (1984).
-
(1984)
J. Urol.
, vol.132
, pp. 800-803
-
-
Borden, E.C.1
Groveman, D.S.2
Nasu, T.3
Reznikoff, C.4
Bryan, G.T.5
-
7
-
-
0026610596
-
Bacillus Calmette-Guérin immunotherapy: Techniques and results
-
BROSMAN, S.A., Bacillus Calmette-Guérin immunotherapy: techniques and results. Urol. Clin. North Amer., 19, 557-564 (1992).
-
(1992)
Urol. Clin. North Amer.
, vol.19
, pp. 557-564
-
-
Brosman, S.A.1
-
8
-
-
0027290546
-
Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder
-
CARBALLIDO, J., MOLTO, L., MANZANO, L., OLIVIER, C., SALMERON, O. and ALVAREZ-MON, M., Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder. Cancer, 72, 1743-1748 (1993).
-
(1993)
Cancer
, vol.72
, pp. 1743-1748
-
-
Carballido, J.1
Molto, L.2
Manzano, L.3
Olivier, C.4
Salmeron, O.5
Alvarez-Mon, M.6
-
9
-
-
0027361393
-
Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG)
-
DE REIJKE, T.M., VOS, P.C., DE BOER, E.C., BEVERS, R.F., DE MUINCK KEIZER, W.H., KURTH, K.H. and SCHAMHART, D.H., Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol. Res., 21, 349-352 (1993).
-
(1993)
Urol. Res.
, vol.21
, pp. 349-352
-
-
De Reijke, T.M.1
Vos, P.C.2
De Boer, E.C.3
Bevers, R.F.4
De Muinck Keizer, W.H.5
Kurth, K.H.6
Schamhart, D.H.7
-
10
-
-
0027471685
-
Interferon-α in malignant and viral diseases. A review
-
DORR, R.T., Interferon-α in malignant and viral diseases. A review. Drugs, 45, 177-211 (1993).
-
(1993)
Drugs
, vol.45
, pp. 177-211
-
-
Dorr, R.T.1
-
11
-
-
0029047669
-
Interleukin-6 production by bladder tumors is upregulated by BCG Immunotherapy
-
ESUVARANATHAN, K., ALEXANDROFF, A.B., MCINTYRE M., JACKSON, A.M., PRESCOTT, S., CHISHOLM, G.D. and JAMES, K. Interleukin-6 production by bladder tumors is upregulated by BCG Immunotherapy. J. Urol., 154, 572-575 (1995).
-
(1995)
J. Urol.
, vol.154
, pp. 572-575
-
-
Esuvaranathan, K.1
Alexandroff, A.B.2
Mcintyre, M.3
Jackson, A.M.4
Prescott, S.5
Chisholm, G.D.6
James, K.7
-
12
-
-
0025161718
-
A randomized controlled study of intravesical alpha-2binterferon in carcinoma in situ of the bladder
-
GLASHAN, R.W., A randomized controlled study of intravesical alpha-2binterferon in carcinoma in situ of the bladder. J. Urol., 144, 658-661 (1990).
-
(1990)
J. Urol.
, vol.144
, pp. 658-661
-
-
Glashan, R.W.1
-
13
-
-
0028076834
-
Bacillus Calmette-Guérin (BCG) organisms directly alter the growth of bladder tumour cells
-
JACKSON, A.M., ALEXANDROFF, A.B., FLEMING, D., PRESCOTT, S., CHISHOLM, G.D. and JAMES, K., Bacillus Calmette-Guérin (BCG) organisms directly alter the growth of bladder tumour cells. Int. J. Oncol., 5, 697-703 (1994).
-
(1994)
Int. J. Oncol.
, vol.5
, pp. 697-703
-
-
Jackson, A.M.1
Alexandroff, A.B.2
Fleming, D.3
Prescott, S.4
Chisholm, G.D.5
James, K.6
-
14
-
-
0028915845
-
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy
-
JACKSON, A.M., ALEXANDROFF, A.B., KELLY, R.W., SKIBINSKA, A., ESUVARANATHAN, K., PRESCOTT, S., CHISHOLM, G.D. and JAMES, K., Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin. exp. Immunol., 99, 369-375 (1995).
-
(1995)
Clin. Exp. Immunol.
, vol.99
, pp. 369-375
-
-
Jackson, A.M.1
Alexandroff, A.B.2
Kelly, R.W.3
Skibinska, A.4
Esuvaranathan, K.5
Prescott, S.6
Chisholm, G.D.7
James, K.8
-
15
-
-
0025969827
-
Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients
-
KUO, J.Y., NISHIO, Y., KANAMARU, H., OKADA, Y., KITA, M., IMANISHI, J., KISHIDA, T. and YOSHIDA, O., Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients. Urol. Res., 19, 51-56 (1991).
-
(1991)
Urol. Res.
, vol.19
, pp. 51-56
-
-
Kuo, J.Y.1
Nishio, Y.2
Kanamaru, H.3
Okada, Y.4
Kita, M.5
Imanishi, J.6
Kishida, T.7
Yoshida, O.8
-
16
-
-
0026773464
-
Complications of bacillus Calmette-Guérin immunotherapy
-
LAMM, D.L., Complications of bacillus Calmette-Guérin immunotherapy. Urol. Clin. North Amer., 19, 565-572 (1992).
-
(1992)
Urol. Clin. North Amer.
, vol.19
, pp. 565-572
-
-
Lamm, D.L.1
-
17
-
-
0023193318
-
Requirement of a thymus dependent immune response for BCG-mediated anti-tumour activity
-
LAMM, D.L., RATLIFF, T.L., GILLEN, D. and CATALONA, W.J., Requirement of a thymus dependent immune response for BCG-mediated anti-tumour activity. J. Urol., 137, 155-158 (1987).
-
(1987)
J. Urol.
, vol.137
, pp. 155-158
-
-
Lamm, D.L.1
Ratliff, T.L.2
Gillen, D.3
Catalona, W.J.4
-
18
-
-
0026777899
-
Immunotherapy for superficial bladder cancer
-
MORALES, A. and CURTIS NICKEL, J., Immunotherapy for superficial bladder cancer. Urol. Clin. North Amer., 19, 549-556 (1992).
-
(1992)
Urol. Clin. North Amer.
, vol.19
, pp. 549-556
-
-
Morales, A.1
Curtis Nickel, J.2
-
19
-
-
0017130525
-
Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors
-
MORALES, A., EIDINGER, D. and BRUCE, A.W., Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J. Urol., 16, 180-183 (1976).
-
(1976)
J. Urol.
, vol.16
, pp. 180-183
-
-
Morales, A.1
Eidinger, D.2
Bruce, A.W.3
-
20
-
-
0028099338
-
Cytotoxic effects of alpha- and gamma-interferon and tumor necrosis factor in human bladder tumor cell lines
-
NIELL, H.B., MAUER, A.M. and RADEMACHER, D., Cytotoxic effects of alpha- and gamma-interferon and tumor necrosis factor in human bladder tumor cell lines. Urol. Res., 22, 247-250 (1994).
-
(1994)
Urol. Res.
, vol.22
, pp. 247-250
-
-
Niell, H.B.1
Mauer, A.M.2
Rademacher, D.3
-
21
-
-
0027453842
-
Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer
-
PATARD, J.J., CHOPIN, D.K. and BOCCON GIBOD, L., Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer. World J. Urol., 11, 165-168 (1993).
-
(1993)
World J. Urol.
, vol.11
, pp. 165-168
-
-
Patard, J.J.1
Chopin, D.K.2
Boccon Gibod, L.3
-
22
-
-
0026717957
-
Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall
-
PRESCOTT, S., JAMES, K., HARGREAVE, T.B., CHISHOLM, G.D. and SMYTH, J.F., Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J. Urol., 147, 1636-1642 (1992).
-
(1992)
J. Urol.
, vol.147
, pp. 1636-1642
-
-
Prescott, S.1
James, K.2
Hargreave, T.B.3
Chisholm, G.D.4
Smyth, J.F.5
-
23
-
-
0027179385
-
T-cell subsets required for intravesical BCG immunotherapy for bladder cancer
-
RATLIFF, T.L., RITCHEY, J.K., YUAN, J.J., ANDRIOLE, G.L. and CATALONA, W.J., T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J. Urol., 150, 1018-1023 (1993).
-
(1993)
J. Urol.
, vol.150
, pp. 1018-1023
-
-
Ratliff, T.L.1
Ritchey, J.K.2
Yuan, J.J.3
Andriole, G.L.4
Catalona, W.J.5
-
24
-
-
0026718875
-
Immunotherapeutic alternatives in superficial bladder cancer: Interferon, interleukin-2. and keyhole-limpet hemocyanin
-
SARGENT, E.R. and WILLIAMS, R.D., Immunotherapeutic alternatives in superficial bladder cancer: interferon, interleukin-2. and keyhole-limpet hemocyanin. Urol. Clin. North Amer., 19, 581-590 (1992).
-
(1992)
Urol. Clin. North Amer.
, vol.19
, pp. 581-590
-
-
Sargent, E.R.1
Williams, R.D.2
-
25
-
-
0026739463
-
Minireview. the interferon system
-
SEN, G.C. and LENGYEL, P., Minireview. The interferon system. J. biol. Chem., 267, 5017-5020 (1992).
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 5017-5020
-
-
Sen, G.C.1
Lengyel, P.2
-
26
-
-
0028331926
-
Interferon-activated sienal transduction to the nucleus
-
SHUAI, K., Interferon-activated sienal transduction to the nucleus. Curr. Opin. Cell Biol., 6, 253-259 (1994).
-
(1994)
Curr. Opin. Cell Biol.
, vol.6
, pp. 253-259
-
-
Shuai, K.1
-
27
-
-
0027276842
-
Long-term results and risk factors of tumor recurrence in patients with superficial bladder cancer who were treated by intravesical bacillus Calmette-Guérin (BCG) instillation
-
TACHIBANA, M., NAKAMURA, S., JITSUKAWA, S., DEGUCHI, N., BABA, S., HATA, M. and TAZAKI H., Long-term results and risk factors of tumor recurrence in patients with superficial bladder cancer who were treated by intravesical bacillus Calmette-Guérin (BCG) instillation. Nippon Hinyokika Gakkai Zasshi, 84, 656-661 (1993).
-
(1993)
Nippon Hinyokika Gakkai Zasshi
, vol.84
, pp. 656-661
-
-
Tachibana, M.1
Nakamura, S.2
Jitsukawa, S.3
Deguchi, N.4
Baba, S.5
Hata, M.6
Tazaki, H.7
-
28
-
-
0023839910
-
Alpha-interferon in superficial bladder cancer: A Northern California oncology group study
-
TORTI, F.M. and TWELVE OTHERS. Alpha-interferon in superficial bladder cancer: a Northern California oncology group study. J. clin. Oncol., 6, 476-483 (1988).
-
(1988)
J. Clin. Oncol.
, vol.6
, pp. 476-483
-
-
Torti, F.M.1
-
29
-
-
0028177842
-
Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells
-
ZHANG, K. and KUMAR, R., Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells. Biochem. biophys. Res. Comm., 200, 522-528 (1994).
-
(1994)
Biochem. Biophys. Res. Comm.
, vol.200
, pp. 522-528
-
-
Zhang, K.1
Kumar, R.2
|